intracellular protein anticancer therapeutics and short stranded DNA anticancer therapeutics
We aim to developing intracellular protein anticancer therapeutics and short stranded DNA anticancer therapeutics for colorectal cancer, small cell lung cancer, or pancreatic cancer, etc. through de novo protein design. Priority will be given to students with experience in cell and mouse experiments, or those interested in and with learning experience in artificial intelligence assisted protein design.